Dr. Arap is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 University Of New Mexico Msc 07 4025
Albuquerque, NM 87131Phone+1 505-272-4946Fax+1 505-925-0100
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
- Universidade de Sao Paulo Faculty of MedicineClass of 1983
Certifications & Licensure
- NJ State Medical License 2017 - 2025
- TX State Medical License 2000 - 2022
- NM State Medical License 2013 - 2020
- CT State Medical License 1991 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2003
Publications & Presentations
PubMed
- 151 citationsCoronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate–Induced CardiotoxicityVishnu Chintalgattu, Meredith L. Rees, James C. Culver, Aditya Goel, Tilahu Jiffar
Science Translational Medicine. 2013-05-29 - 36 citationsAn unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironmentPaul J. Mintz, Marina Cardó-Vila, Michael G. Ozawa, Amin Hajitou, Roberto Rangel
Proceedings of the National Academy of Sciences of the United States of America. 2009-02-17 - 621 citationsA Population of Multipotent CD34-Positive Adipose Stromal Cells Share Pericyte and Mesenchymal Surface Markers, Reside in a Periendothelial Location, and Stabilize End...Dmitry O. Traktuev, Stephanie Merfeld-Clauss, Jingling Li, Mikhail G. Kolonin, Wadih Arap
Circulation Research. 2008-01-04
Journal Articles
- Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult DiseaseRichard L Sidman, Leslie A Morrison, Howard Yonas, Wadih Arap, Muhammad O Chohan, JAMA
Press Mentions
- Identifying Potential Treatment for Triple Negative Breast CancerJune 1st, 2021
- $250K Grant Awarded to Rutgers Cancer Institute of New Jersey ResearchersJuly 31st, 2018
- Rutgers Researchers Help Validate Discovery Method to Identify Antibodies That Target TumorsMay 3rd, 2018
- Join now to see all
Grant Support
- Regulation Of The Paracrine Angiogenic Function Of Cardiac Myocytes By CardiomyocNational Heart, Lung, And Blood Institute2011
- Novel Clinical Diagnostic Targets For Detection Of Invasive MOLD AspergillosisNational Institute Of Allergy And Infectious Diseases2010–2011
- Multifunctional Nanoassemblies For Ligand-Directed Imaging And Therapy Of EndocriNational Cancer Institute2010–2011
- Molecular Targeting Of Lymphatic Endothelial Receptors For Ligand-Directed ImaginNational Cancer Institute2009–2010
- Molecular Diversity In Bladder CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Mapping Vacular Diversity Of Human CancerNational Cancer Institute2005–2006
- Imaging Tumor Blood Vessels In Bone Metastases From Breast CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Stem Cell-Brain Tumor Interplay &In Vivo Phage DisplayNational Cancer Institute2003–2005
- Mapping Vacular Diversity Of Human CancerNational Cancer Institute2004
- Imaging Tumor Blood Vessels In Bone MetastasesNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Molecular Heterogeneity Of Tumor Blood VesselsNational Cancer Institute2001–2002
- Blood Vessel Targeting In Prostate Cancer TreatmentNational Cancer Institute2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: